Works matching IS 08876924 AND DT 2009 AND VI 23 AND IP 3

Results: 35

Expression profiling of persistent polyclonal B-cell lymphocytosis suggests constitutive expression of the AP-1 transcription complex and downregulation of Fas-apoptotic and TGFβ signalling pathways.

Published in:

2009

By:

Lawrie, C. H.;
Shilling, R.;
Troussard, X.;
Cattan, H.;
Mossafa, H.;
Pezzella, F.;
Boultwood, J.;
Wainscoat, J. S.;
Hatton, C. S. R.

Publication type:

Letter

Alterations of NFIA in chronic malignant myeloid diseases.

Published in:

2009

By:

Bernard, F.;
Gelsi-Boyer, V.;
Murati, A.;
Giraudier, S.;
Trouplin, V.;
Adélaïde, J.;
Rey, J.;
Olschwang, S.;
Vainchenker, W.;
Chaffanet, M.;
Vey, N.;
Mozziconacci, M. J.;
Birnbaum, D.

Publication type:

Letter

Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma.

Published in:

2009

By:

Mao, X.;
Li, X.;
Sprangers, R.;
Wang, X.;
Venugopal, A.;
Wood, T.;
Zhang, Y.;
Kuntz, D. A.;
Coe, E.;
Trudel, S.;
Rose, D.;
Batey, R. A.;
Kay, L. E.;
Schimmer, A. D.

Publication type:

Letter

Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor.

Published in:

2009

By:

Brownlow, N.;
Mol, C.;
Hayford, C.;
Ghaem-Maghami, S.;
Dibb, N. J.

Publication type:

Letter

Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol.

Published in:

2009

By:

Zaher, M.;
Akrout, I.;
Mirshahi, M.;
Kolb, J.-P.;
Billard, C.

Publication type:

research

Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.

Published in:

2009

By:

Wang, S. S.;
Maurer, M. J.;
Morton, L. M.;
Habermann, T. M.;
Davis, S.;
Cozen, W.;
Lynch, C. F.;
Severson, R. K.;
Rothman, N.;
Chanock, S. J.;
Hartge, P.;
Cerhan, J. R.

Publication type:

Letter

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany.

Published in:

2009

By:

Rohrbacher, M.;
Berger, U.;
Hochhaus, A.;
Metzgeroth, G.;
Adam, K.;
Lahaye, T.;
Saussele, S.;
Müller, M. C.;
Hasford, J.;
Heimpel, H.;
Hehlmann, R.

Publication type:

Letter

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells.

Published in:

2009

By:

Minnema, M. C.;
van der Veer, M. S.;
Aarts, T.;
Emmelot, M.;
Mutis, T.;
Lokhorst, H. M.

Publication type:

Letter

Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial.

Published in:

2009

By:

Willems, E.;
Baron, F.;
Baudoux, E.;
Wanten, N.;
Seidel, L.;
Vanbellinghen, J.-F.;
Herens, C.;
Gothot, A.;
Frère, P.;
Bonnet, C.;
Hafraoui, K.;
Vanstraelen, G.;
Fillet, G.;
Beguin, Y.

Publication type:

Letter

UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.

Published in:

2009

By:

Szpurka, H.;
Gondek, L. P.;
Mohan, S. R.;
Hsi, E. D.;
Theil, K. S.;
Maciejewski, J. P.

Publication type:

Letter

A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin.

Published in:

2009

By:

Russell, L. J.;
De Castro, D. G.;
Griffiths, M.;
Telford, N.;
Bernard, O.;
Panzer-Grümayer, R.;
Heidenreich, O.;
Moorman, A. V.;
Harrison, C. J.

Publication type:

Letter

Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.

Published in:

2009

By:

Struski, S.;
Gervais, C.;
Helias, C.;
Herbrecht, R.;
Audhuy, B.;
Mauvieux, L.

Publication type:

Letter

PET imaging of T cells derived from umbilical cord blood.

Published in:

2009

By:

Singh, H.;
Najjar, A. M.;
Olivares, S.;
Nishii, R.;
Mukhopadhyay, U.;
Alauddin, M.;
Manuri, P. R.;
Huls, H.;
Lee, D. A.;
Dotti, G.;
Bollard, C.;
Simmons, P. J.;
Shpall, E. J.;
Champlin, R. E.;
Gelovani, J. G.;
Cooper, L. J. N.

Publication type:

Letter

Survivin expression in the bone marrow of patients with severe congenital neutropenia.

Published in:

2009

By:

Carlsson, G.;
Boxhammer, S.;
Garwicz, D.;
Henter, J. I.;
Palmblad, J.;
Nordenskjöld, M.;
Porwit, A.;
Fadeel, B.

Publication type:

Letter

17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.

Published in:

2009

By:

Dijkstra, M. K.;
van Lom, K.;
Tielemans, D.;
Elstrodt, F.;
Langerak, A. W.;
van 't Veer, M. B.;
Jongen-Lavrencic, M.

Publication type:

Letter

The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed–Sternberg cells.

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 565, doi. 10.1038/leu.2008.314

By:

Knecht, H.;
Sawan, B.;
Lichtensztejn, D.;
Lemieux, B.;
Wellinger, R. J.;
Mai, S.

Publication type:

Article

Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells.

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 535, doi. 10.1038/leu.2008.301

By:

Knödler, A.;
Schmidt, S. M.;
Bringmann, A.;
Weck, M. M.;
Brauer, K. M.;
Holderried, T. A. W.;
Heine, A.-K.;
Grünebach, F.;
Brossart, P.

Publication type:

Article

Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.

Published in:

2009

By:

Schmiegelow, K.;
Forestier, E.;
Kristinsson, J.;
Söderhäll, S.;
Vettenranta, K.;
Weinshilboum, R.;
Wesenberg, F.;
Söderhäll, S;
Nordic Society of Paediatric Haematology and Oncology

Publication type:

journal article

Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.

Published in:

2009

By:

Deenik, W.;
Beverloo, H. B.;
van der Poel-van de Luytgaarde, S. C. P. A. M.;
Wattel, M. M.;
van Esser, J. W. J.;
Valk, P. J. M.;
Cornelissen, J. J.

Publication type:

Letter

Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy.

Published in:

2009

By:

Faderl, S.;
Ferrajoli, A.;
Frankfurt, O.;
Pettitt, A.

Publication type:

journal article

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.

Published in:

2009

By:

Feldman, A. L.;
Law, M.;
Remstein, E. D.;
Macon, W. R.;
Erickson, L. A.;
Grogg, K. L.;
Kurtin, P. J.;
Dogan, A.

Publication type:

journal article

Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia.

Published in:

2009

By:

Rocha, V.;
Porcher, R.;
Fernandes, J. F.;
Filion, A.;
Bittencourt, H.;
Silva Jr., W.;
Vilela, G.;
Zanette, D. L.;
Ferry, C.;
Larghero, J.;
Devergie, A.;
Ribaud, P.;
Skvortsova, Y.;
Tamouza, R.;
Gluckman, E.;
Socie, G.;
Zago, M. A.;
Silva, W Jr

Publication type:

journal article

Treatment of newly diagnosed myeloma.

Published in:

2009

By:

Palumbo, A.;
Rajkumar, S. V.

Publication type:

journal article

Inhibitor of apoptosis proteins in hematological malignancies.

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 467, doi. 10.1038/leu.2008.329

By:

Fulda, S.

Publication type:

Article

Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 528, doi. 10.1038/leu.2008.324

By:

Ratei, R.;
Basso, G.;
Dworzak, M.;
Gaipa, G.;
Veltroni, M.;
Rhein, P.;
Biondi, A.;
Schrappe, M.;
Ludwig, W.-D.;
Karawajew, L.

Publication type:

Article

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.

Published in:

2009

By:

Willemze, R.;
Rodrigues, C. A.;
Labopin, M.;
Sanz, G.;
Michel, G.;
Socié, G.;
Rio, B.;
Sirvent, A.;
Renaud, M.;
Madero, L.;
Mohty, M.;
Ferra, C.;
Garnier, F.;
Loiseau, P.;
Garcia, J.;
Lecchi, L.;
Kögler, G.;
Beguin, Y.;
Navarrete, C.;
Devos, T.

Publication type:

journal article

A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 501, doi. 10.1038/leu.2008.326

By:

Bolli, N.;
De Marco, M. F.;
Martelli, M. P.;
Bigerna, B.;
Pucciarini, A.;
Rossi, R.;
Mannucci, R.;
Manes, N.;
Pettirossi, V.;
Pileri, S. A.;
Nicoletti, I.;
Falini, B.

Publication type:

Article

Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 510, doi. 10.1038/leu.2008.333

By:

Kotsianidis, I.;
Bouchliou, I.;
Nakou, E.;
Spanoudakis, E.;
Margaritis, D.;
Christophoridou, A. V.;
Anastasiades, A.;
Tsigalou, C.;
Bourikas, G.;
Karadimitris, A.;
Tsatalas, C.

Publication type:

Article

Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 477, doi. 10.1038/leu.2008.334

By:

Remsing Rix, L. L.;
Rix, U.;
Colinge, J.;
Hantschel, O.;
Bennett, K. L.;
Stranzl, T.;
Müller, A.;
Baumgartner, C.;
Valent, P.;
Augustin, M.;
Till, J. H.;
Superti-Furga, G.

Publication type:

Article

Pathogenesis of myeloma bone disease.

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 435, doi. 10.1038/leu.2008.336

By:

Roodman, G. D.

Publication type:

Article

The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 519, doi. 10.1038/leu.2008.338

By:

Giannopoulos, K.;
Mertens, D.;
Bühler, A.;
Barth, T. F. E.;
Idler, I.;
Möller, P.;
Kröber, A.;
Greiner, J.;
Chocholska, S.;
Dmoszyñska, A.;
Roliñski, J.;
Döhner, H.;
Stilgenbauer, S.;
Schmitt, M.

Publication type:

Article

CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy.

Published in:

Leukemia (08876924), 2009, v. 23, n. 3, p. 486, doi. 10.1038/leu.2008.339

By:

Pérez-García, A.;
Brunet, S.;
Berlanga, J. J.;
Tormo, M.;
Nomdedeu, J.;
Guardia, R.;
Ribera, J. M.;
Heras, I.;
Llorente, A.;
Hoyos, M.;
Esteve, J.;
Besalduch, J.;
Bueno, J.;
Sierra, J.;
Gallardo, D.

Publication type:

Article

Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon?

Published in:

2009

By:

Ribatti, D.

Publication type:

Editorial

Role of autologous and allogeneic stem cell transplantation in myeloma.

Published in:

2009

By:

Bensinger, W. I.

Publication type:

journal article

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.

Published in:

2009

By:

Willemze, R;
Rodrigues, C A;
Labopin, M;
Sanz, G;
Michel, G;
Socié, G;
Rio, B;
Sirvent, A;
Renaud, M;
Madero, L;
Mohty, M;
Ferra, C;
Garnier, F;
Loiseau, P;
Garcia, J;
Lecchi, L;
Kögler, G;
Beguin, Y;
Navarrete, C;
Devos, T

Publication type:

Correction Notice

Works matching IS 08876924 AND DT 2009 AND VI 23 AND IP 3

Expression profiling of persistent polyclonal B-cell lymphocytosis suggests constitutive expression of the AP-1 transcription complex and downregulation of Fas-apoptotic and TGFβ signalling pathways.

Alterations of NFIA in chronic malignant myeloid diseases.

Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma.

Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor.

Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol.

Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany.

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4<sup>+</sup>Foxp3<sup>+</sup> T cells.

Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial.

UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.

A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin.

Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.

PET imaging of T cells derived from umbilical cord blood.

Survivin expression in the bone marrow of patients with severe congenital neutropenia.

17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.

The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed–Sternberg cells.

Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells.

Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.

Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.

Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy.

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.

Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia.

Treatment of newly diagnosed myeloma.

Inhibitor of apoptosis proteins in hematological malignancies.

Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.

A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.

Kinetics, function and bone marrow trafficking of CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>+</sup> regulatory T cells in myelodysplastic syndromes (MDS).

Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.

Pathogenesis of myeloma bone disease.

The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.

CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy.

Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon?

Role of autologous and allogeneic stem cell transplantation in myeloma.

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.